Discover the top 33 companies transforming the single-cell analysis market, including BD, Thermo Fisher Scientific Inc., Danaher Corporation, and other industry leaders. Backed by a market projected to grow from $3.81B to $7.56B by 2030 at a CAGR of 14.7%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights.

Download PDF Brochure:“Click Here”

Spotlights on the Industry’s Top Single Cell Analysis Companies

BD

BD (Becton, Dickinson and Company) is a global medical technology leader that advances health by improving medical discovery, diagnostics, and care delivery. In the single cell analysis market, BD provides comprehensive solutions through its Life Sciences segment, offering high-parameter flow cytometry, single-cell multiomics tools, and automated platforms like the BD Rhapsody system. By integrating proteomic and genomic data, BD enables researchers to gain deeper insights into complex biological systems, maintaining a strong position in both clinical and research environments worldwide.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is the world leader in serving science, providing an extensive ecosystem of technologies for life sciences research and clinical diagnostics. The company offers a diverse range of single cell analysis solutions, including advanced flow cytometry, mass spectrometry, and automated sample preparation systems under industry-leading brands like Invitrogen and Applied Biosystems. Thermo Fisher’s commitment to innovation and its global scale allow it to support high-throughput single-cell workflows, facilitating breakthroughs in oncology, immunology, and drug development.

Danaher Corporation

Danaher Corporation is a global science and technology innovator that operates a prominent Life Sciences division featuring companies such as Cytiva, Beckman Coulter Life Sciences, and SCIEX. Through these subsidiaries, Danaher provides critical tools for single cell analysis, including cell sorting systems, high-resolution imaging, and advanced genomic and proteomic analytical platforms. The company leverages the Danaher Business System to drive continuous improvement in its single-cell workflows, helping biopharmaceutical researchers move from discovery to delivery with greater speed and precision.

10x Genomics

10x Genomics is a specialized life science technology company dedicated to building products that interrogate biological systems at a resolution and scale that matches the complexity of biology. As a pioneer in the single cell analysis market, its Chromium, Visium, and Xenium platforms enable researchers to perform high-resolution single-cell transcriptomics, epigenomics, and spatial analysis. 10x Genomics’ integrated solutions of instruments, consumables, and software have become foundational tools for modern biological research, particularly in mapping the cellular landscapes of health and disease.

Merck KGaA

Merck KGaA is a leading science and technology company headquartered in Germany, operating across Healthcare, Life Science, and Electronics. Within its Life Science segment, the company provides essential tools and services for single cell analysis, including high-quality reagents, specialized cell culture media, and advanced filtration and separation technologies. Merck focuses on empowering researchers with reliable workflows for cell isolation and characterization, supporting the development of next-generation therapies through its global reach and deep technical expertise in bioprocessing and laboratory science.

Agilent Technologies, Inc.

Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing laboratories worldwide with instruments, services, and consumables. The company supports the single cell analysis market through its advanced cell analysis portfolio, which includes Seahorse XF technology for measuring cell metabolism and high-resolution imaging systems. Agilent’s focus on providing integrated workflows and robust data analytics helps researchers understand cellular function and dynamics, positioning the company as a key partner in academic and pharmaceutical research.

QIAGEN

QIAGEN is a leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from biological samples. In the single cell analysis market, QIAGEN offers specialized kits and technologies for the isolation of single cells and the subsequent amplification of genomic and transcriptomic material. Their portfolio, which includes advanced bioinformatics tools for data interpretation, enables researchers to conduct high-quality single-cell sequencing and analysis, particularly in the fields of oncology and prenatal diagnostics.

Illumina, Inc.

Illumina, Inc. is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. As the dominant provider of next-generation sequencing (NGS) platforms, Illumina is central to the single cell analysis market, providing the primary readout technology for most single-cell genomic and transcriptomic workflows. The company continues to innovate with high-throughput systems and specialized library preparation kits designed to handle the unique requirements of single-cell data, driving the expansion of single-cell research into clinical applications.

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing a broad range of innovative products for the life science research and clinical diagnostic markets. The company provides critical solutions for single cell analysis, including droplet digital PCR (ddPCR) systems and cell sorting technologies that enable high-precision quantification and isolation of individual cells. Bio-Rad’s expertise in partition-based technologies allows researchers to achieve high sensitivity and reproducibility in single-cell studies, supporting advancements in genomics and proteomics research.

DiaSorin S.p.A.

DiaSorin S.p.A. is an Italian multinational biotechnology company that specializes in the production of diagnostic tests and platforms. While primarily focused on immunodiagnostics and molecular diagnostics, DiaSorin has expanded its presence in the life sciences research market through the acquisition of Luminex Corporation. This move has integrated advanced multiplexing technologies and flow cytometry capabilities into its portfolio, allowing the company to support single cell analysis applications that require high-throughput protein and nucleic acid detection in clinical and research settings.

Standard BioTools

Standard BioTools, formerly known as Fluidigm, is a life science tools company focused on developing technologies that provide a comprehensive view of biology. The company is a pioneer in microfluidics and mass cytometry (CyTOF technology), which allows for the simultaneous analysis of dozens of proteins at the single-cell level. Standard BioTools’ platforms are widely used for deep immune profiling and single-cell genomics, helping researchers uncover cellular heterogeneity and complex regulatory networks in various disease states.

Tecan Trading AG

Tecan Trading AG is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company contributes to the single cell analysis market by providing highly automated liquid handling systems and specialized sample preparation platforms. Tecan’s automation solutions are designed to standardize and scale single-cell workflows, reducing human error and increasing throughput for complex procedures like library preparation for single-cell sequencing and high-content screening.

Sartorius AG

Sartorius AG is a leading international partner for life science research and the biopharmaceutical industry, specializing in innovative laboratory and bioprocessing technologies. In the single cell analysis sector, Sartorius offers advanced live-cell imaging and analysis systems, such as the Incucyte platform, which allow for the continuous monitoring of individual cells over time. Their solutions focus on providing real-time biological insights and high-throughput data to accelerate the discovery and development of new drugs and cell-based therapies.

Corning Incorporated

Corning Incorporated leverages its deep expertise in materials science to provide innovative glass and plastic consumables essential for life science research. In the single cell analysis market, Corning offers specialized cell culture surfaces and microplates designed to facilitate single-cell isolation and expansion. Their products support high-resolution imaging and high-throughput screening, providing the necessary environment for researchers to maintain cell viability and behavior during complex single-cell experimental procedures.

Cytek Biosciences

Cytek Biosciences is a leading cell analysis solutions company that has revolutionized flow cytometry through its Full Spectrum Profiling (FSP) technology. Their advanced systems, such as the Aurora and Northern Lights series, allow researchers to detect a vast number of fluorophores from a single cell with high sensitivity and resolution. Cytek’s technology enables high-parameter single cell analysis that was previously difficult to achieve, making it a critical provider for immunology, oncology, and personalized medicine research.

Takara Bio Inc.

Takara Bio Inc. is a Japanese biotechnology company that provides a wide array of products and services to support life science research, including genomic and proteomic analysis. The company offers specialized solutions for single-cell genomics through its SMART-seq technology, which is widely recognized for its high sensitivity and ability to generate full-length cDNA from individual cells. Takara Bio’s tools enable researchers to perform detailed transcriptomic analysis of rare cell populations, driving discoveries in developmental biology and regenerative medicine.

bioMérieux

bioMérieux is a global leader in the field of in vitro diagnostics, specializing in the diagnosis of infectious diseases. While its primary focus is clinical diagnostics, the company invests in advanced molecular technologies that support the understanding of microbial heterogeneity. Through its research and development efforts, bioMérieux explores single cell analysis techniques to improve the detection of drug-resistant pathogens and the study of host-pathogen interactions, aiming to translate single-cell insights into more precise and faster diagnostic solutions.

Revvity

Revvity, formerly part of PerkinElmer, is a science-driven solutions provider that delivers end-to-end expertise in health science, from discovery to cure. In the single cell analysis market, Revvity offers a comprehensive portfolio including high-content imaging systems, automated liquid handling, and specialized reagents for single-cell omics. The company’s integrated workflows are designed to help researchers decode cellular complexity and accelerate the development of precision medicines, particularly in the fields of oncology and rare diseases.

Bio-Techne

Bio-Techne is a global life sciences company that provides high-quality reagents, instruments, and services for research and clinical diagnostics. The company supports single cell analysis through its innovative ProteinSimple branded platforms, which offer automated Western blotting and multiplexed protein detection at the single-cell level. Bio-Techne’s portfolio also includes a vast range of antibodies and cytokines, providing researchers with the essential tools needed to identify and characterize specific cell types and their signaling pathways in complex biological samples.

PacBio

PacBio (Pacific Biosciences of California, Inc.) is a premier provider of high-accuracy long-read sequencing systems that enable a comprehensive view of genomes, transcriptomes, and epigenomes. In the single cell analysis market, PacBio’s HiFi sequencing technology allows for the detection of full-length transcripts and complex structural variations within individual cells. This capability provides a higher level of detail than traditional short-read methods, helping researchers to accurately characterize isoforms and genetic diversity at the single-cell level.

Bruker

Bruker is a global manufacturer of high-performance scientific instruments for molecular and materials research. The company has expanded its presence in the single cell analysis market through the acquisition of PhenomeX (formerly Berkeley Lights and IsoPlexis). This integration provides Bruker with advanced platforms for functional single-cell proteomics and cell biology, enabling researchers to characterize the behavior and secretions of individual cells. Bruker’s focus on high-resolution mass spectrometry and spatial biology further complements its single-cell capabilities for deep biological phenotyping.

Promega Corporation

Promega Corporation is a worldwide leader in providing innovative solutions and technical support to the life sciences industry. The company offers a wide range of reagents and assays that are critical for single cell analysis, including highly sensitive bioluminescent and fluorescent tools for monitoring cellular processes. Promega’s products are used for cell viability testing, reporter gene assays, and nucleic acid purification, providing the fundamental components required for researchers to conduct precise and reproducible single-cell experiments in drug discovery and basic research.

Oxford Nanopore Technologies plc

Oxford Nanopore Technologies plc provides a unique, real-time nanopore-based sequencing technology that allows for the analysis of DNA and RNA of any length. In the single cell analysis market, their portable and scalable platforms, such as the MinION and PromethION, enable researchers to perform long-read single-cell sequencing in diverse environments. This technology is particularly valuable for identifying full-length RNA isoforms and detecting base modifications at the single-cell level, offering a real-time, comprehensive perspective on cellular activity.

Singleron Biotechnologies

Singleron Biotechnologies is an innovative molecular diagnostics company specializing in high-throughput single-cell analysis solutions. The company provides a comprehensive workflow that includes tissue dissociation, single-cell processing instruments, reagents, and bioinformatics software. Singleron’s focus on providing end-to-end, user-friendly platforms aims to make single-cell technology more accessible for clinical research and drug development, particularly in the Asia-Pacific region and Europe.

Cell Microsystems

Cell Microsystems is a life science tools company that provides innovative solutions for the isolation and analysis of single cells. Its primary product, the CellRaft AIR System, uses a unique microraft technology to enable the gentle and efficient imaging, identification, and recovery of individual cells from heterogeneous populations. This platform is designed to maintain cell viability and phenotypic characteristics, making it an ideal tool for researchers involved in CRISPR screening, stem cell research, and monoclonal antibody development.

NanoCellect Biomedical

NanoCellect Biomedical is a biotechnology company focused on developing user-friendly microfluidic solutions for cell analysis and sorting. Its flagship product, the WOLF Cell Sorter, utilizes a gentle microfluidic-based sorting mechanism that minimizes cell stress and maintains high viability. This technology is specifically designed for researchers who require a sterile, easy-to-use, and cost-effective system for single-cell isolation, supporting applications in genomics, cell line development, and clinical research.

RareCyte, Inc.

RareCyte, Inc. is a life sciences company that provides high-performance platforms for the identification and analysis of rare cells, such as circulating tumor cells (CTCs). The company’s integrated technology includes specialized sample preparation, high-resolution imaging, and single-cell retrieval systems. RareCyte’s solutions enable researchers and clinicians to perform detailed molecular characterization of rare cells from liquid biopsies, providing critical insights for oncology research and personalized medicine.

BICO

BICO (formerly Cellink) is a leading “bio-convergence” company that combines biology, engineering, and data science to create innovative life science solutions. Through its diverse portfolio of companies, BICO offers technologies for single-cell dispensing, 3D bioprinting, and automated cell imaging. Their single-cell isolation systems focus on precision and high throughput, providing researchers with the tools needed to build complex tissue models and perform detailed cellular analysis for drug discovery and regenerative medicine.

Menarini Group

The Menarini Group is a leading international pharmaceutical and diagnostic company based in Italy. Its presence in the single cell analysis market is highlighted by Menarini Silicon Biosystems, which provides the DEPArray technology. This unique platform uses dielectrophoresis to isolate and recover individual cells with 100% purity from complex samples. Menarini’s technology is particularly valuable for oncological research, allowing for the precise genetic analysis of single tumor and stromal cells to advance precision medicine strategies.

Apogee Flow Systems Ltd

Apogee Flow Systems Ltd is a specialist manufacturer of high-sensitivity flow cytometers designed for the detection of small particles, including extracellular vesicles and individual microbes. The company’s systems provide exceptional resolution and sensitivity, enabling researchers to perform single-cell analysis on very small biological units that are often difficult to detect with conventional flow cytometers. Apogee’s technology is widely used in environmental microbiology, immunology, and the study of cell-to-cell communication.

Creative Biolabs

Creative Biolabs is a leading service provider and product manufacturer in the field of antibody discovery and life sciences research. The company offers a wide range of single cell analysis services, including single-cell sequencing and specialized cell isolation techniques. Creative Biolabs leverages its expertise in biotechnology to support researchers in characterizing cellular heterogeneity and identifying novel therapeutic targets, providing customized solutions for complex single-cell projects across various therapeutic areas.

Sphere Bio

Sphere Bio is an emerging biotechnology company focused on developing advanced materials and platforms for single-cell analysis and therapeutic delivery. By utilizing proprietary spherical technologies, the company aims to enhance the sensitivity and specificity of single-cell assays. Sphere Bio’s innovative approach focuses on overcoming the technical limitations of current single-cell workflows, providing researchers with new tools to explore cellular functions and interactions with greater detail and efficiency.

Yokogawa Electric Corporation

Yokogawa Electric Corporation is a global provider of industrial automation, control, and measurement solutions, which has expanded its reach into the life sciences through high-precision imaging and analysis technologies. The company’s Single Cellome system uses proprietary confocal imaging and micro-sampling technology to isolate and analyze specific components within individual cells. Yokogawa’s solutions focus on providing detailed spatial and functional insights into cellular behavior, supporting drug discovery and basic biological research with advanced engineering and automation.

Download PDF Brochure:“Click Here”